Literature DB >> 9328807

Psychopharmacotherapy for addictive and comorbid disorders: current studies.

B M Pechter1, N S Miller.   

Abstract

Proper diagnosis of comorbid disorders is crucial in treatment planning for the dually diagnosed. Since psychoactive substance use can obfuscate the diagnosis, special care must be taken to exclude organically based syndromes. Adequate periods of abstinence should first be achieved and subsequently the patient re-examined for residual symptoms compatible with a nonaddictive, nonsubstance-induced psychiatric disorder. The integration of concurrent treatment of both the mental and the addictive disorders appears to be the best approach for treatment of comorbid psychiatric and addictive disorders. An abstinence-based model that typically utilizes a 12-step group therapy is often employed for the addictive illnesses. Other forms of psychosocial therapies such as case managers are being used as well. Presently, physicians' prescribing practices for comorbid addicted patients are based on traditional approaches to use of medications in psychiatric patients, and their attitudes towards addictive disorders may play a significant role in determining the overall success of treatment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9328807     DOI: 10.1080/10550889709511141

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  1 in total

1.  Anxiety sensitivity risk reduction in smokers: A randomized control trial examining effects on panic.

Authors:  Norman B Schmidt; Amanda M Raines; Nicholas P Allan; Michael J Zvolensky
Journal:  Behav Res Ther       Date:  2015-12-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.